insights_auto
Why is HALO up १३.०२%?
Dive Deeperchevron_right
HALO:BMV
Halozyme Therapeutics, Inc.
MX$ २,२२५.००
arrow_upward
+१३.०२%(+२५६.३१) 1D
अक्टोबर १५, १४:००:०० GMT-६ · MXN
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HALO...
Open
MX$ २,२२५.००
High
MX$ २,२२५.००
Low
MX$ २,२२५.००
Mkt. cap
१३.७९ अरब
Avg. vol.
४४०.००
Volume
५०.००
52-wk high
MX$ २,२२५.००
52-wk low
MX$ १,१२६.००
No. of employees
४२३
Open
MX$ २,२२५.००
High
MX$ २,२२५.००
Low
MX$ २,२२५.००
Mkt. cap
१३.७९ अरब
Avg. vol.
४४०.००
Volume
५०.००
52-wk high
MX$ २,२२५.००
52-wk low
MX$ १,१२६.००
No. of employees
४२३
News stories
From web sources and news partners
CNBC
·
१ घण्टा पहिले
Inside Edge’s Todd Gordon: Halozyme Therapeutics are beating estimates; raised full-year guidance
Yahoo Finance
·
९ घण्टा पहिले
Here's How Much a $1000 Investment in Halozyme Therapeutics Made 10 Years Ago Would Be Worth Today
Timothy Sykes
·
२३ घण्टा पहिले
HALO Stock Climbs As Dutch Court Injunction Lifts Bullish Bets
StocksToTrade
·
२३ घण्टा पहिले
HALO Stock Climbs As Patent Win And Deals Lift Outlook
Profile
Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment.
The company was founded in 1998 and went public in 2004. Halozyme is headquartered in San Diego, California. Wikipedia
About Halozyme Therapeutics, Inc.
CEOHelen I. Torley
Employees४२३
Founded१९९८
Headquartersसान डिएगो, क्यालिफोर्निया, संयुक्त राज्य अमेरिका
Sector-
Websitehalozyme.com